Delivery Order SPE2DB20D3101-SPE2DB24FRDR3
- Not listed
- This federal contract award, valued at $14,625.76, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with an ultimate completion date of April 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22D2007|SPE2DB23FJ2HF) valued at $21,945.86 for the supply of SHINGRIX VIAL KITS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $9,501.50 for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The contract, a delivery order with a firm fixed price, has an ultimate completion date of February 14, 2022 and was awarded on February 11, 2022. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,391.80, is a delivery order for SHINGRIX vial kits. It is a firm-fixed-price contract with a period of performance through February 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $42,919.50 firm fixed-price delivery order is for the supply of SHINGRIX vial kits, a pharmaceutical product, with an ultimate completion date of January 4, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,806.56 for the supply of SHINGRIX vial kits. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a period of performance through April 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,519.96 firm fixed-price delivery order is for SHINGRIX VIAL KITS and has an ultimate completion date of April 28, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026....
- This federal contract award, valued at $13,404.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a medical product, with an ultimate completion date of April 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the contract is structured as a Delivery Order under a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SHINGRIX vial kits (Contract ID: SPE2DB24D1034|SPE2DB24FWBB1) to the Defense Logistics Agency (DLA), a defense agency. The $3,312.24 firm fixed-price delivery order has a completion date of July 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $10,803.53 and is a delivery order with a firm fixed-price pricing type. The contract has an ultimate completion date of May 15, 2023, and was awarded on May 12, 2023. This...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRDR3Delivery Order
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,040.80, is for the delivery of SHINGRIX Vial Kits, a pharmaceutical product. The delivery order has a firm fixed price pricing type and a completion date of March 13, 2024. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award reviewed does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 3/12/24 |